Gelteq Limited
Update in progressGELS (NasdaqCM)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
Gelteq Limited develops and commercializes white-label, gel-based delivery systems for both humans and animals in the United States and Australia. The company provides edible gel formulations for prescription drugs, nutraceuticals, pet care, and other products, including sports supplements and over-the-counter items. Established in 2017, Gelteq is headquartered in Clayton, Australia.
Company score
- Sentiment
- 0.43
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.20
- Governance
- 0.00
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.06
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.25
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqCM (NCM)
- LocationAustralia
- CEOMr. Nathan Jacob Givoni
- Founded2017
- Employees7
- Websitewww.gelteq.com
Identifiers
- ISINAU0000218109
- FIGIBBG019FVCPG8
- CIK0001920092